Streetbeat News

Revenues

SXTP

60 Degrees Pharmaceuticals has announced the publication of a study titled 'Trial Planned to Evaluate Safety and Efficacy of Tafenoquine + Atovaquone/Azithromycin in Hospitalized Babesiosis Patients' in The Journal of Infectious Diseases. This publication marks a significant step in the research and development of treatments for Babesiosis, a disease caused by Babesia parasites. The study aims to assess the safety and efficacy of a combination treatment involving Tafenoquine and Atovaquone/Azithromycin in hospitalized patients suffering from this condition.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:00 pm

IMXI

International Money Express (IMXI) forecasts Q2 revenue to be between $171.5M-$176.8M, slightly below the estimated $176.115M, and adjusted EPS to range from $0.54-$0.58, closely aligning with the estimated $0.56.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:00 pm

BAND

Bandwidth (NASDAQ:BAND) received varied analyst ratings in the last quarter, with a shift towards a more positive outlook. The average 12-month price target for BAND has been raised to $26.5, indicating a 13.98% increase from the previous target of $23.25. Analysts from Baird, Canaccord Genuity, Barclays, and Keybanc have all raised their price targets, reflecting optimism about the company's future performance. Despite this, Bandwidth's market capitalization is below industry benchmarks, and its financial performance shows mixed results with a positive revenue trend but lower ROE and ROA compared to industry averages.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 12:00 pm

TWKS

Thoughtworks Holding (NASDAQ:TWKS) has been evaluated by 5 financial analysts over the last three months, showing a shift towards a more cautious stance with 1 somewhat bullish and 4 indifferent ratings recently. The average 12-month price target for TWKS has been adjusted to $3.93, down from $4.75, indicating a 17.26% decrease. Analysts from firms like Baird, Citigroup, RBC Capital, and Piper Sandler have updated their ratings and price targets, reflecting changes in market dynamics and company performance. Thoughtworks faces revenue challenges with a -18.78% growth over 3 months and has a below-industry average market capitalization, yet it maintains strong profitability metrics such as net margin and ROE.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 12:00 pm

FRSH

11 analysts have recently shared mixed evaluations of Freshworks (NASDAQ:FRSH), with a range of bullish to bearish perspectives. The average 12-month price target for FRSH is now $21.82, down from $25.38, indicating a 14.03% decrease. Analysts from firms like Needham, Canaccord Genuity, and Barclays have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. Freshworks's financial indicators show a revenue growth rate of 20.23% but lag behind industry peers in profitability and efficiency metrics.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 12:00 pm

VCEL

Vericel has updated its FY24 revenue guidance, raising the range from $237M-$241M to $238M-$242M, slightly above the estimated $239.24M. The company also reaffirmed its profitability guidance, expecting a gross margin of around 70% and an adjusted EBITDA margin of about 20%.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 11:58 am

HLLY

Holley has projected its Q2 net sales to be between $165M-$175M, falling short of the estimated $183.088M. Despite this, the company has reaffirmed its full-year 2024 outlook, expecting net sales to range from $640M-$680M, aligning closely with the estimated $661.559M.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 11:57 am

SGHC

Super Group reported a Q1 2024 revenue of €379.3M, surpassing estimates and marking a 12% increase from the previous year, driven by growth in Africa and North America. The company's profit was €41.0M, including a significant gain from the disposal of the B2B division of Digital Gaming Corporation Limited. Adjusted EBITDA rose by 29% to €46.5M, and monthly active customers increased by 33%. Cash and cash equivalents grew to €289.2M, supported by strong operating inflows and despite outflows for investments and financing activities.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 11:56 am

BWAY

BrainsWay has reaffirmed its FY24 revenue guidance, projecting revenues between $37M-$40M, indicating a 16% to 26% growth over its FY23 revenue. The company also expects to maintain its profitability momentum and positive cash generation throughout 2024.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 11:52 am

GFF

Griffon Corporation (GFF) has updated its 2024 financial outlook, now expecting revenue of $2.65 billion, up from $2.6 billion, and adjusted EBITDA of $555 million, up from $525 million. These adjustments reflect stronger than anticipated results from its Home & Building Products (HBP) segment in the first half. Other financial guidance for 2024 remains unchanged.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 11:51 am